2024 Lawyers of the Year
The Anti-Fraud Coalition bestows the 2024 Lawyers of the Year Award to the Berger Montague & Reese Marketos teams for their efforts in the Janssen and PharMerica cases.
2024 Whistleblower of the Year
The Anti-Fraud Coalition bestowed its Whistleblower of the Year Award to Dr. Rayme Edler for her efforts to protect patients in Escambia County, Florida.
The Middle District of Florida Court Finds the Qui Tam Provision of the False Claims Act Unconstitutional because a Relator is an “Officer” of the United States
We are only recovering a fraction of the billions of dollars being lost to fraud. Whistleblowers are stepping up if the government has the resources to run with their cases.
STATEMENT: TAF Coalition Statement on Zafirov Holding
“This holding is an outlier, breaking with precedent, including the decisions of every appellate court that has considered this question."
More Resources Are Needed in the Fight on Fraud
We are only recovering a fraction of the billions of dollars being lost to fraud. Whistleblowers are stepping up if the government has the resources to run with their cases.
An Ounce of Prevention is Worth Billions for a Cure
With $10.2 billion worth of critical function services, opportunities for fraud are everywhere.
Which U.S. Attorneys’ Offices Brought in the Highest Recoveries in the Past Five Years?
In today's Fraud By The Numbers, we're diving into the various U.S. Attorney Offices and how much has been recovered.
DOJ's Civil Cyber-Fraud Initiative: A Milestone in Cybersecurity Enforcement
After launching three years ago, the Civil Cyber-Fraud Initiative continues to rack up wins -- becoming a critical tool to address and deter cybersecurity lapses.
The Government Spends Much Less on Fraud Cases than Big Companies Spend Defending Them
One U.S. Chamber of Commerce-funded survey of Fortune 200 companies found that the average total cost of outside litigation was $115 million per respondent in 2008.
Pill Talk: Negotiating, Lobbying, and Inflating Drug Prices
From 2000 to 2020, the government increased its spending on prescription drugs by 91 percent, now it's trying to rein in costs.
